Medicine & Life Sciences
Abatacept
5%
Aldehyde Reductase
12%
Antihypertensive Agents
6%
Basement Membrane
11%
Biphasic Insulins
6%
Blood Glucose
13%
Blood Pressure
12%
C-Peptide
11%
Cardiovascular Diseases
7%
Carvedilol
13%
Clinical Trials
7%
Diabetes Complications
25%
Diabetes Mellitus
19%
Diabetic Nephropathies
9%
Diabetic Neuropathies
15%
Diabetic Retinopathy
9%
Epidemiology
6%
Ergocalciferols
6%
Erythrocytes
6%
Fasting
14%
Glucagon
17%
Glucose
36%
Glycated Hemoglobin A
16%
Hemoglobins
8%
Hyperglycemia
20%
Hyperinsulinism
7%
Hypertension
13%
Hypertriglyceridemia
5%
Hypoglycemia
11%
Hypoglycemic Agents
9%
Infusion Pumps
5%
Injections
8%
Insulin
100%
Insulin Aspart
10%
insulin aspart, insulin aspart protamine drug combination 30:70
18%
Insulin Glargine
13%
Insulin Lispro
8%
Insulin Receptor
5%
Insulin Resistance
15%
Insulin Secretion
5%
Kidney
7%
Lipoproteins
6%
Liraglutide
5%
Liver
5%
Meals
14%
Metformin
31%
methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate
6%
Metoprolol
10%
Multicenter Studies
6%
Peripheral Nervous System Diseases
7%
Pioglitazone
6%
Placebos
25%
Prediabetic State
8%
repaglinide
14%
Rosiglitazone
9%
Safety
10%
Skeletal Muscle
5%
Somatostatin
7%
Subcutaneous Infusions
21%
T-Lymphocytes
5%
Therapeutics
22%
Thiazolidinediones
6%
Troglitazone
6%
Type 1 Diabetes Mellitus
73%
Type 2 Diabetes Mellitus
78%
very low density lipoprotein triglyceride
5%
Weight Gain
8%